Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctioncalcium,diacylglycerol-dependent serine/threonine kinase activity

PRKCA PRKCG

3.29e-0521152GO:0004698
GeneOntologyMolecularFunctionhistone H3T6 kinase activity

PRKCA PRKCB

3.29e-0521152GO:0035403
GeneOntologyMolecularFunctionG protein-coupled receptor activity

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 OR2F1 OPRL1 FZD5 OR10K1 OR10K2 ADGRE1

4.68e-0588411516GO:0004930
GeneOntologyMolecularFunctionodorant binding

OR5AK2 OR5I1 OR8K5 OR5K3 OR10K1 OR10K2

9.39e-051271156GO:0005549
GeneOntologyMolecularFunction6-phosphofructokinase activity

PFKL PFKP

9.83e-0531152GO:0003872
GeneOntologyMolecularFunctiondiacylglycerol-dependent serine/threonine kinase activity

PRKCA PRKCB PRKCG

9.87e-05161153GO:0004697
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

ATR RIPK1 GRK7 PSKH1 PFKL PFKP CDC42BPB JAK3 PIK3CG PRKCA PRKCB PRKCG KIT

2.24e-0470911513GO:0016773
GeneOntologyMolecularFunctiontransmembrane signaling receptor activity

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 PTCH1 OR2F1 OPRL1 FZD5 TLR4 OR10K1 OR10K2 ADGRE1 KIT

2.55e-04135311519GO:0004888
GeneOntologyMolecularFunctionfructose-6-phosphate binding

PFKL PFKP

3.25e-0451152GO:0070095
GeneOntologyMolecularFunctionkinase activity

ATR RIPK1 GRK7 PSKH1 PFKL PFKP CDC42BPB JAK3 PIK3CG PRKCA PRKCB PRKCG KIT

4.57e-0476411513GO:0016301
GeneOntologyMolecularFunctionhistone kinase activity

ATR PRKCA PRKCB

5.49e-04281153GO:0035173
GeneOntologyMolecularFunctionphosphofructokinase activity

PFKL PFKP

6.78e-0471152GO:0008443
GeneOntologyMolecularFunctionprotein kinase activity

ATR RIPK1 GRK7 PSKH1 CDC42BPB JAK3 PIK3CG PRKCA PRKCB PRKCG KIT

6.95e-0460011511GO:0004672
GeneOntologyMolecularFunctionolfactory receptor activity

OR2F2 OR10H5 OR5AK2 OR5I1 OR8K5 OR5K3 OR2F1 OR10K1 OR10K2

8.76e-044311159GO:0004984
GeneOntologyMolecularFunctiontransferase activity, transferring phosphorus-containing groups

ATR RIPK1 GRK7 PSKH1 PFKL PFKP CDC42BPB JAK3 PIK3CG PRKCA PRKCB PRKCG KIT PARP12

9.97e-0493811514GO:0016772
GeneOntologyMolecularFunctionprotein serine/threonine kinase activity

ATR RIPK1 GRK7 PSKH1 CDC42BPB PIK3CG PRKCA PRKCB PRKCG

1.11e-034461159GO:0004674
GeneOntologyMolecularFunctionprotein serine kinase activity

ATR RIPK1 PSKH1 CDC42BPB PIK3CG PRKCA PRKCB PRKCG

1.21e-033631158GO:0106310
GeneOntologyMolecularFunctioncalcium-dependent protein serine/threonine kinase activity

PRKCA PRKCG

1.44e-03101152GO:0009931
GeneOntologyMolecularFunctionamide transmembrane transporter activity

AQP3 SLC19A1 SLC25A47

1.81e-03421153GO:0042887
GeneOntologyMolecularFunctionhistone H3 kinase activity

PRKCA PRKCB

2.09e-03121152GO:0140996
GeneOntologyBiologicalProcessG protein-coupled receptor signaling pathway

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 GRK7 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 OR2F1 ADCYAP1 OPRL1 PIK3CG FZD5 ARHGEF1 OR10K1 OR10K2 PRKCA PRKCB ADGRE1 DAGLA

1.65e-06139511323GO:0007186
GeneOntologyBiologicalProcessmulti-pass transmembrane protein insertion into ER membrane

NOMO1 NOMO2 NOMO3

1.31e-0591133GO:0160063
GeneOntologyBiologicalProcesspositive regulation of miRNA-mediated gene silencing

RIPK1 PUM2 PUM1

3.40e-05121133GO:2000637
GeneOntologyBiologicalProcesspositive regulation of post-transcriptional gene silencing by RNA

RIPK1 PUM2 PUM1

4.40e-05131133GO:1900370
GeneOntologyBiologicalProcesspositive regulation of post-transcriptional gene silencing

RIPK1 PUM2 PUM1

4.40e-05131133GO:0060148
GeneOntologyBiologicalProcessnuclear membrane disassembly

ATR PRKCA PRKCB

4.40e-05131133GO:0051081
GeneOntologyBiologicalProcessmembrane disassembly

ATR PRKCA PRKCB

5.58e-05141133GO:0030397
GeneOntologyBiologicalProcessregulation of dendritic cell cytokine production

JAK3 TLR4 KIT

1.23e-04181133GO:0002730
GeneOntologyBiologicalProcessdendritic cell cytokine production

JAK3 TLR4 KIT

1.46e-04191133GO:0002371
GeneOntologyBiologicalProcessdetection of stimulus

OR2F2 OR10H5 OR5AK2 OR5I1 GRK7 OR8K5 OR5K3 OR2F1 NLRC4 TLR4 OR10K1 OR10K2 KIT

1.63e-0472211313GO:0051606
GeneOntologyCellularComponentmulti-pass translocon complex

NOMO1 NOMO2 NOMO3

1.37e-0591163GO:0160064
GeneOntologyCellularComponentER membrane insertion complex

NOMO1 NOMO2 NOMO3

5.80e-05141163GO:0072379
GeneOntologyCellularComponent6-phosphofructokinase complex

PFKL PFKP

9.13e-0531162GO:0005945
HumanPhenoLymphopenia

ATR RIPK1 TCN2 MDM4 NLRC4 JAK3 PIGA SLC19A1 PIK3CG ARHGEF1

1.83e-052863610HP:0001888
HumanPhenoAbnormality of cells of the lymphoid lineage

ATR RIPK1 TCN2 MDM4 NLRC4 JAK3 PIGA SLC19A1 PIK3CG ARHGEF1

2.55e-052973610HP:0012140
HumanPhenoMyalgia

SH3TC2 ACAD9 CAPN3 ANO5 MDM4 NLRC4 TLR4 KIT

3.55e-05187368HP:0003326
HumanPhenoAbnormal lymphocyte count

ATR RIPK1 TCN2 MDM4 NLRC4 JAK3 PIGA SLC19A1 PIK3CG ARHGEF1

5.27e-053233610HP:0040088
MousePhenodecreased liver cholesterol level

FOXO1 SCP2 C1QTNF1 SLC27A5

1.42e-0526814MP:0010026
DomainProtein_kinase_C_a/b/g

PRKCA PRKCB PRKCG

2.21e-0731143IPR014375
DomainDUF2012

NOMO1 NOMO2 NOMO3

8.82e-0741143PF09430
DomainDUF2012

NOMO1 NOMO2 NOMO3

8.82e-0741143IPR019008
DomainARM-like

MROH9 ATR MROH2A MROH5 PUM2 ZYG11B HSPBP1 ECPAS PUM1 PPP6R3

6.13e-0627011410IPR011989
DomainDAG/PE-bd

CDC42BPB PRKCA PRKCB PRKCG

7.27e-06211144IPR020454
DomainARM-type_fold

MROH9 ATR MROH2A MROH5 PUM2 ZYG11B HSPBP1 ECPAS PIK3CG PUM1 PPP6R3

7.29e-0633911411IPR016024
DomainCarb-bd-like_fold

NOMO1 NOMO2 NOMO3

1.21e-0581143IPR013784
DomainAGC-kinase_C

GRK7 CDC42BPB PRKCA PRKCB PRKCG

2.31e-05561145IPR000961
DomainAGC_KINASE_CTER

GRK7 CDC42BPB PRKCA PRKCB PRKCG

2.31e-05561145PS51285
DomainS_TK_X

GRK7 CDC42BPB PRKCA PRKCB PRKCG

2.31e-05561145SM00133
DomainPumilio_RNA-bd

PUM2 PUM1

3.69e-0521142IPR033712
DomainGPCR_Rhodpsn_7TM

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 OR2F1 OPRL1 OR10K1 OR10K2

5.82e-0567011414IPR017452
DomainCarboxyPept_regulatory_dom

NOMO1 NOMO2 NOMO3

6.06e-05131143IPR014766
Domain-

NOMO1 NOMO2 NOMO3

6.06e-051311432.60.40.1120
Domain7tm_1

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 OR2F1 OPRL1 OR10K1 OR10K2

6.50e-0567711414PF00001
Domain-

MROH9 ATR MROH5 PUM2 ZYG11B HSPBP1 ECPAS PUM1

6.56e-0522211481.25.10.10
DomainG_PROTEIN_RECEP_F1_1

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 OR2F1 OPRL1 OR10K1 OR10K2

7.37e-0568511414PS00237
DomainPkinase_C

CDC42BPB PRKCA PRKCB PRKCG

7.44e-05371144IPR017892
DomainG_PROTEIN_RECEP_F1_2

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 OR2F1 OPRL1 OR10K1 OR10K2

8.09e-0569111414PS50262
DomainGPCR_Rhodpsn

CCR10 OR2F2 OR10H5 OR5AK2 OR5I1 MRGPRF OR8K5 OR5K3 TAAR5 SSTR1 OR2F1 OPRL1 OR10K1 OR10K2

8.21e-0569211414IPR000276
Domain6-Pfructokinase_euk

PFKL PFKP

1.10e-0431142IPR009161
DomainPUF

PUM2 PUM1

1.10e-0431142PF00806
DomainPUM_HD

PUM2 PUM1

1.10e-0431142PS50303
DomainPHOSPHOFRUCTOKINASE

PFKL PFKP

1.10e-0431142PS00433
DomainPUM-HD

PUM2 PUM1

1.10e-0431142IPR033133
DomainPhosphofructokinase_CS

PFKL PFKP

1.10e-0431142IPR015912
DomainPFK

PFKL PFKP

1.10e-0431142PF00365
DomainATP_PFK

PFKL PFKP

1.10e-0431142IPR022953
DomainPhosphofructokinase_dom

PFKL PFKP

1.10e-0431142IPR000023
DomainPkinase_C

CDC42BPB PRKCA PRKCB PRKCG

1.23e-04421144PF00433
DomainCarboxyPept-like_regulatory

NOMO1 NOMO2 NOMO3

1.41e-04171143IPR008969
DomainPUM

PUM2 PUM1

2.20e-0441142PS50302
DomainPumilio_RNA-bd_rpt

PUM2 PUM1

2.20e-0441142IPR001313
DomainPumilio

PUM2 PUM1

2.20e-0441142SM00025
DomainC1_1

CDC42BPB PRKCA PRKCB PRKCG

4.05e-04571144PF00130
DomainKinase-like_dom

ATR RIPK1 GRK7 PSKH1 CDC42BPB JAK3 PIK3CG PRKCA PRKCB PRKCG KIT

4.82e-0454211411IPR011009
DomainZF_DAG_PE_1

CDC42BPB PRKCA PRKCB PRKCG

6.31e-04641144PS00479
DomainZF_DAG_PE_2

CDC42BPB PRKCA PRKCB PRKCG

6.31e-04641144PS50081
DomainC1

CDC42BPB PRKCA PRKCB PRKCG

6.69e-04651144SM00109
DomainOlfact_rcpt

OR2F2 OR10H5 OR5AK2 OR5I1 OR8K5 OR5K3 OR2F1 OR10K1 OR10K2

6.85e-043931149IPR000725
DomainPE/DAG-bd

CDC42BPB PRKCA PRKCB PRKCG

7.09e-04661144IPR002219
DomainYip1

YIPF7 YIPF3

7.60e-0471142IPR006977
DomainYip1

YIPF7 YIPF3

7.60e-0471142PF04893
Domain-

PIK3CG PRKCA PRKCB PRKCG CCDC33

2.15e-0314811452.60.40.150
DomainProtein_kinase_ATP_BS

GRK7 PSKH1 CDC42BPB JAK3 PRKCA PRKCB PRKCG KIT

2.27e-033791148IPR017441
DomainWWE

DTX1 PARP12

2.34e-03121142PF02825
DomainWWE-dom

DTX1 PARP12

2.34e-03121142IPR004170
DomainWWE

DTX1 PARP12

2.34e-03121142PS50918
DomainProt_kinase_dom

RIPK1 GRK7 PSKH1 CDC42BPB JAK3 PRKCA PRKCB PRKCG KIT

3.07e-034891149IPR000719
DomainPROTEIN_KINASE_DOM

RIPK1 GRK7 PSKH1 CDC42BPB JAK3 PRKCA PRKCB PRKCG KIT

3.24e-034931149PS50011
DomainC2_dom

PIK3CG PRKCA PRKCB PRKCG CCDC33

3.34e-031641145IPR000008
DomainPI3/4_kinase_CS

ATR PIK3CG

3.68e-03151142IPR018936
Domain-

ATR PIK3CG

4.19e-031611421.10.1070.11
DomainPI3Kc

ATR PIK3CG

4.19e-03161142SM00146
DomainPI3_PI4_kinase

ATR PIK3CG

5.30e-03181142PF00454
DomainPI3_4_KINASE_1

ATR PIK3CG

5.30e-03181142PS00915
DomainPI3_4_KINASE_2

ATR PIK3CG

5.30e-03181142PS00916
DomainPI3/4_kinase_cat_dom

ATR PIK3CG

5.30e-03181142IPR000403
DomainPI3_4_KINASE_3

ATR PIK3CG

5.30e-03181142PS50290
PathwayREACTOME_DISINHIBITION_OF_SNARE_FORMATION

PRKCA PRKCB PRKCG

2.25e-065873M26920
PathwayBIOCARTA_PAR1_PATHWAY

PIK3CG ARHGEF1 PRKCA PRKCB

4.89e-0619874MM1514
PathwayBIOCARTA_PAR1_PATHWAY

PIK3CG ARHGEF1 PRKCA PRKCB

4.89e-0619874M3494
PathwayWP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES

WNT7A PTCH1 PIK3CG FZD5 PRKCA PRKCB PRKCG

8.09e-06118877M39852
PathwayBIOCARTA_EDG1_PATHWAY

PIK3CG SPHKAP PRKCA PRKCB

9.09e-0622874M10579
PathwayWP_GLIOBLASTOMA_SIGNALING

FOXO1 MDM4 PIK3CG PRKCA PRKCB PRKCG

1.20e-0583876M39637
PathwayKEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

1.24e-058873M47555
PathwayKEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

1.24e-058873M47479
PathwayBIOCARTA_PLC_PATHWAY

PIK3CG PRKCA PRKCB

1.86e-059873M22029
PathwayBIOCARTA_PLC_PATHWAY

PIK3CG PRKCA PRKCB

1.86e-059873MM1551
PathwayREACTOME_SIGNALING_BY_GPCR

CCR10 WNT7A TAAR5 SSTR1 PTCH1 ADCYAP1 OPRL1 PIK3CG FZD5 ARHGEF1 PRKCA PRKCB PRKCG ADGRE1 DAGLA

2.29e-057028715M746
PathwayPID_TXA2PATHWAY

PIK3CG ARHGEF1 PRKCA PRKCB PRKCG

2.38e-0556875M99
PathwayPID_IL8_CXCR1_PATHWAY

PIK3CG PRKCA PRKCB PRKCG

2.47e-0528874M252
PathwayKEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

2.64e-0510873M47644
PathwayREACTOME_SENSORY_PERCEPTION

TRPM4 OR2F2 OR10H5 OR5AK2 OR5I1 GRK7 OR8K5 OR5K3 EPB41L3 OR2F1 OR10K1 SLC17A8 OR10K2 PRKCA

3.21e-056368714M41834
PathwayWP_WNT_SIGNALING

WNT7A FZD5 PRKCA PRKCB PRKCG

3.61e-0561875MM15893
PathwayKEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

3.61e-0511873M47637
PathwayBIOCARTA_MYOSIN_PATHWAY

ARHGEF1 PRKCA PRKCB

3.61e-0511873M7014
PathwayKEGG_MELANOGENESIS

WNT7A FZD5 PRKCA PRKCB PRKCG KIT

3.68e-05101876M7761
PathwayKEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

4.80e-0512873M47597
PathwayKEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

4.80e-0512873M47649
PathwayKEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

4.80e-0512873M47628
PathwayPID_IL8_CXCR2_PATHWAY

PIK3CG PRKCA PRKCB PRKCG

5.45e-0534874M210
PathwayKEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

6.21e-0513873M47656
PathwayKEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

7.87e-0514873M47383
PathwayKEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

7.87e-0514873M47384
PathwayWP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY

PIK3CG PRKCA PRKCB PRKCG

9.44e-0539874M39905
PathwayKEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

9.79e-0515873M47382
PathwayREACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4

PRKCA PRKCB PRKCG

9.79e-0515873M27413
PathwayWP_OPIOID_RECEPTOR_PATHWAYS

OPRL1 PIK3CG TLR4 PRKCG

1.15e-0441874M48338
PathwayKEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION

PIK3CG PRKCA PRKCB PRKCG

1.27e-0442874M16473
PathwayPID_THROMBIN_PAR1_PATHWAY

ARHGEF1 PRKCA PRKCB PRKCG

1.39e-0443874M238
PathwayREACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS

PRKCA PRKCB PRKCG

1.45e-0417873M5488
PathwayKEGG_TIGHT_JUNCTION

MYH13 EPB41L3 CLDN10 PRKCA PRKCB PRKCG

1.63e-04132876M11355
PathwayKEGG_PATHWAYS_IN_CANCER

FOXO1 WNT7A PTCH1 PIK3CG FZD5 PRKCA PRKCB PRKCG KIT

1.74e-04325879M12868
PathwayBIOCARTA_KERATINOCYTE_PATHWAY

RIPK1 PRKCA PRKCB PRKCG

1.81e-0446874M19118
PathwayBIOCARTA_KERATINOCYTE_PATHWAY

RIPK1 PRKCA PRKCB PRKCG

1.81e-0446874MM1428
PathwayKEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY

PRKCA PRKCB PRKCG

2.05e-0419873M47596
PathwayBIOCARTA_EDG1_PATHWAY

PIK3CG PRKCA PRKCB

2.40e-0420873MM1456
PathwayKEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

2.79e-0421873M47638
PathwayREACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS

WNT7A PTCH1 ADCYAP1 FZD5 ADGRE1

2.84e-0494875M797
PathwayKEGG_NON_SMALL_CELL_LUNG_CANCER

PIK3CG PRKCA PRKCB PRKCG

3.38e-0454874M19818
PathwayBIOCARTA_ION_PATHWAY

PRKCA PRKCB

3.72e-045872MM1574
PathwayBIOCARTA_PLCD_PATHWAY

PRKCA PRKCB

3.72e-045872MM1587
PathwayBIOCARTA_ION_PATHWAY

PRKCA PRKCB

3.72e-045872M22059
PathwayBIOCARTA_PLCD_PATHWAY

PRKCA PRKCB

3.72e-045872M22080
PathwayWP_WNT_SIGNALING_AND_PLURIPOTENCY

WNT7A FZD5 PRKCA PRKCB PRKCG

3.97e-04101875M39387
PathwayWP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY

WNT7A FZD5 PRKCA PRKCB PRKCG

3.97e-04101875MM15829
PathwayBIOCARTA_TPO_PATHWAY

PIK3CG PRKCA PRKCB

4.18e-0424873M11520
PathwayWP_ADHD_AND_AUTISM_ASD_PATHWAYS

TCN2 PNPO SLC19A1 CNTN5 PRKCA PRKCB PRKCG KIT DAGLA

4.27e-04367879M48346
PathwayBIOCARTA_TPO_PATHWAY

PIK3CG PRKCA PRKCB

4.73e-0425873MM1519
PathwayKEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

5.33e-0426873M47557
PathwayBIOCARTA_VEGF_PATHWAY

PIK3CG PRKCA PRKCB

5.97e-0427873M12975
PathwayBIOCARTA_GH_PATHWAY

PIK3CG PRKCA PRKCB

5.97e-0427873M9043
PathwayWP_WNT_SIGNALING_WP428

WNT7A FZD5 PRKCA PRKCB PRKCG

6.63e-04113875M39669
PathwayBIOCARTA_PDGF_PATHWAY

PIK3CG PRKCA PRKCB

6.65e-0428873M2529
PathwayKEGG_GLIOMA

PIK3CG PRKCA PRKCB PRKCG

6.88e-0465874M1835
PathwayBIOCARTA_PDGF_PATHWAY

PIK3CG PRKCA PRKCB

7.39e-0429873MM1452
PathwayKEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION

CLDN10 PIK3CG PRKCA PRKCB PRKCG

7.47e-04116875M2164
PathwayBIOCARTA_ERBB4_PATHWAY

PRKCA PRKCB

7.75e-047872MM1563
PathwayBIOCARTA_PKC_PATHWAY

PRKCA PRKCB

7.75e-047872MM1572
PathwayBIOCARTA_ERBB4_PATHWAY

PRKCA PRKCB

7.75e-047872M22043
PathwayBIOCARTA_PKC_PATHWAY

PRKCA PRKCB

7.75e-047872M22057
PathwayWP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS

PIGV PNPO

7.75e-047872M39767
PathwayKEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY

PRKCA PRKCB PRKCG

9.01e-0431873M47554
PathwayREACTOME_TRAFFICKING_OF_AMPA_RECEPTORS

PRKCA PRKCB PRKCG

9.01e-0431873M7223
PathwayWP_KIT_RECEPTOR_SIGNALING_PATHWAY

PIK3CG PRKCA PRKCB KIT

9.60e-0471874MM15947
PathwayWP_NONSMALL_CELL_LUNG_CANCER

JAK3 PRKCA PRKCB PRKCG

1.01e-0372874M39738
PathwayREACTOME_OLFACTORY_SIGNALING_PATHWAY

OR2F2 OR10H5 OR5AK2 OR5I1 OR8K5 OR5K3 OR2F1 OR10K1 OR10K2

1.06e-03417879M4072
PathwayBIOCARTA_GH_PATHWAY

PIK3CG PRKCA PRKCB

1.08e-0333873MM1404
PathwayWP_CANCER_PATHWAYS

FOXO1 WNT7A PTCH1 JAK3 FZD5 ARHGEF1 PRKCA PRKCB PRKCG KIT

1.11e-035078710M48302
PathwayWP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3

TLR4 PRKCA PRKCB PRKCG

1.18e-0375874M39568
PathwayKEGG_VEGF_SIGNALING_PATHWAY

PIK3CG PRKCA PRKCB PRKCG

1.24e-0376874M1749
PathwayKEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM

PIK3CG PRKCA PRKCB PRKCG

1.24e-0376874M9052
PathwayREACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH

RIPK1 TLR4

1.32e-039872M27192
PathwayBIOCARTA_SRCRPTP_PATHWAY

PRKCA PRKCB

1.64e-0310872MM1341
PathwayBIOCARTA_AGPCR_PATHWAY

PRKCA PRKCB

1.64e-0310872MM1352
PathwayREACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH

RIPK1 TLR4

1.64e-0310872MM14905
PathwayBIOCARTA_CBL_PATHWAY

PRKCA PRKCB

2.00e-0311872MM1360
PathwayBIOCARTA_SRCRPTP_PATHWAY

PRKCA PRKCB

2.00e-0311872M10994
PathwayBIOCARTA_AGPCR_PATHWAY

PRKCA PRKCB

2.00e-0311872M19829
PathwayKEGG_ERBB_SIGNALING_PATHWAY

PIK3CG PRKCA PRKCB PRKCG

2.04e-0387874M12467
PathwayWP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION

PRKCA PRKCB PRKCG

2.04e-0341873M39655
PathwayREACTOME_GPCR_LIGAND_BINDING

CCR10 WNT7A TAAR5 SSTR1 PTCH1 ADCYAP1 OPRL1 FZD5 ADGRE1

2.18e-03463879M507
PathwayBIOCARTA_TCR_PATHWAY

PIK3CG PRKCA PRKCB

2.19e-0342873MM1504
PathwayWP_G_PROTEIN_SIGNALING_PATHWAYS

ARHGEF1 PRKCA PRKCB PRKCG

2.31e-0390874MM15882
PathwayBIOCARTA_CBL_PATHWAY

PRKCA PRKCB

2.39e-0312872M16973
PathwayWP_G_PROTEIN_SIGNALING

ARHGEF1 PRKCA PRKCB PRKCG

2.40e-0391874M39426
PathwayKEGG_WNT_SIGNALING_PATHWAY

WNT7A FZD5 PRKCA PRKCB PRKCG

2.41e-03151875M19428
PathwayWP_HEPATITIS_B_INFECTION

JAK3 TLR4 PRKCA PRKCB PRKCG

2.41e-03151875M39801
PathwayREACTOME_PCP_CE_PATHWAY

FZD5 PRKCA PRKCB PRKCG

2.50e-0392874M27322
PathwayWP_ERBB_SIGNALING

FOXO1 PRKCA PRKCB PRKCG

2.50e-0392874M39715
PathwayBIOCARTA_TCR_PATHWAY

PIK3CG PRKCA PRKCB

2.50e-0344873M19784
PathwayKEGG_OLFACTORY_TRANSDUCTION

OR2F2 OR10H5 OR5AK2 OR5I1 OR8K5 OR2F1 OR10K1 OR10K2

2.74e-03389878M14091
PathwayWP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION

PRKCA PRKCB PRKCG

2.85e-0346873M46450
PathwayKEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS

PIK3CG PRKCA PRKCB PRKCG

2.92e-0396874M16121
PathwayWP_INSULIN_SIGNALING

FOXO1 PFKL PIK3CG PRKCA PRKCB

3.09e-03160875MM15956
PathwayWP_INSULIN_SIGNALING

FOXO1 PFKL PIK3CG PRKCA PRKCB

3.09e-03160875M39482
PathwayWP_HIPPO_SIGNALING_REGULATION

PRKCA PRKCB PRKCG KIT

3.15e-0398874M39830
PathwayREACTOME_G_ALPHA_Z_SIGNALLING_EVENTS

PRKCA PRKCB PRKCG

3.21e-0348873M10775
Pubmed

PKCβ phosphorylates PI3Kγ to activate it and release it from GPCR control.

PIK3CG PRKCA PRKCB PRKCG

5.86e-105116423824069
Pubmed

Protein kinase C as a molecular machine for decoding calcium and diacylglycerol signals.

PRKCA PRKCB PRKCG

3.62e-08311639814702
Pubmed

Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration.

NOMO1 NOMO2 NOMO3

3.62e-083116336011023
Pubmed

Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C.

PIK3CG PRKCA KIT

3.62e-08311637520444
Pubmed

Protein and molecular characterization of hippocampal protein kinase C in C57BL/6 and DBA/2 mice.

PRKCA PRKCB PRKCG

3.62e-08311637760054
Pubmed

Desmosomal adhesiveness is developmentally regulated in the mouse embryo and modulated during trophectoderm migration.

PRKCA PRKCB PRKCG

3.62e-083116322819675
Pubmed

Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways.

PRKCA PRKCB PRKCG

3.62e-08311633755548
Pubmed

Phorbol diester-induced alterations in the expression of protein kinase C isozymes and their mRNAs. Analysis in wild-type and phorbol diester-resistant HL-60 cell clones.

PRKCA PRKCB PRKCG

3.62e-08311631714454
Pubmed

Conventional protein kinase C plays a critical role in negative regulation of CD98-induced homotypic aggregation.

PRKCA PRKCB PRKCG

3.62e-083116319895572
Pubmed

Protein kinase C{alpha}, but not PKC{beta} or PKC{gamma}, regulates contractility and heart failure susceptibility: implications for ruboxistaurin as a novel therapeutic approach.

PRKCA PRKCB PRKCG

3.62e-083116319556521
Pubmed

Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes.

NOMO1 NOMO2 NOMO3

3.62e-083116325576386
Pubmed

Calcium-Dependent Protein Kinase C Is Not Required for Post-Tetanic Potentiation at the Hippocampal CA3 to CA1 Synapse.

PRKCA PRKCB PRKCG

3.62e-083116327307229
Pubmed

Serine phosphorylation of syndecan-2 proteoglycan cytoplasmic domain.

PRKCA PRKCB PRKCG

1.44e-07411639244383
Pubmed

Protein kinase C phosphorylation of threonine at position 888 in Ca2+o-sensing receptor (CaR) inhibits coupling to Ca2+ store release.

PRKCA PRKCB PRKCG

1.44e-07411639694886
Pubmed

Characterization of a 7.5-kDa protein kinase C substrate (RC3 protein, neurogranin) from rat brain.

PRKCA PRKCB PRKCG

1.44e-07411638080473
Pubmed

Phosphorylation of connexin43 on serine368 by protein kinase C regulates gap junctional communication.

PRKCA PRKCB PRKCG

1.44e-074116310871288
Pubmed

Phosphorylation of Munc-18/n-Sec1/rbSec1 by protein kinase C: its implication in regulating the interaction of Munc-18/n-Sec1/rbSec1 with syntaxin.

PRKCA PRKCB PRKCG

1.44e-07411638631738
Pubmed

Cell cycle phase-specific phosphorylation of human topoisomerase II alpha. Evidence of a role for protein kinase C.

PRKCA PRKCB PRKCG

1.44e-07411637499337
Pubmed

Regulation of ARNO nucleotide exchange by a PH domain electrostatic switch.

PRKCA PRKCB PRKCG

1.44e-074116310531036
Pubmed

Protein kinase C phosphorylation of syntaxin 4 in thrombin-activated human platelets.

PRKCA PRKCB PRKCG

1.44e-074116310856305
Pubmed

Regulation of spontaneous meiosis resumption in mouse oocytes by various conventional PKC isozymes depends on cellular compartmentalization.

PRKCA PRKCB PRKCG

1.44e-074116315367584
Pubmed

Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology.

NOMO1 NOMO2 NOMO3

1.44e-074116331833031
Pubmed

Physiological regulation of Munc18/nSec1 phosphorylation on serine-313.

PRKCA PRKCB PRKCG

1.44e-074116312950453
Pubmed

Presynaptic Short-Term Plasticity Persists in the Absence of PKC Phosphorylation of Munc18-1.

PRKCA PRKCB PRKCG

1.44e-074116334290081
Pubmed

Phosphorylation of eIF-4E on serine 209 by protein kinase C is inhibited by the translational repressors, 4E-binding proteins.

PRKCA PRKCB PRKCG

1.44e-07411638662663
Pubmed

Protein kinase C phosphorylates RGS2 and modulates its capacity for negative regulation of Galpha 11 signaling.

PRKCA PRKCB PRKCG

1.44e-074116311063746
Pubmed

A locus for autosomal recessive pseudoxanthoma elasticum, with penetrance of vascular symptoms in carriers, maps to chromosome 16p13.1.

NOMO1 NOMO2 NOMO3

1.44e-07411639267806
Pubmed

G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization.

TLR4 PRKCA PRKCB PRKCG

1.56e-0715116424478091
Pubmed

Location of mouse and human genes corresponding to conserved canine olfactory receptor gene subfamilies.

OR2F2 OR5I1 PFKL OR2F1

2.70e-071711649545490
Pubmed

A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells.

PRKCA PRKCB PRKCG

3.60e-07511637513693
Pubmed

Role of two conserved cytoplasmic threonine residues (T410 and T412) in CD5 signaling.

PRKCA PRKCB PRKCG

3.60e-075116311123317
Pubmed

Phosphorylation of vitronectin on Ser362 by protein kinase C attenuates its cleavage by plasmin.

PRKCA PRKCB PRKCG

3.60e-07511639030777
Pubmed

Phosphorylation of serine 1106 in the catalytic domain of topoisomerase II alpha regulates enzymatic activity and drug sensitivity.

PRKCA PRKCB PRKCG

3.60e-075116312569090
Pubmed

Cell type-specific expression of the genes for the protein kinase C family: down regulation of mRNAs for PKC alpha and nPKC epsilon upon in vitro differentiation of a mouse neuroblastoma cell line neuro 2a.

PRKCA PRKCB PRKCG

3.60e-07511632590242
Pubmed

PKCα integrates spatiotemporally distinct Ca2+ and autocrine BDNF signaling to facilitate synaptic plasticity.

PRKCA PRKCB PRKCG

3.60e-075116330013171
Pubmed

Rapid State-Dependent Alteration in Kv3 Channel Availability Drives Flexible Synaptic Signaling Dependent on Somatic Subthreshold Depolarization.

PRKCA PRKCB PRKCG

3.60e-075116328228266
Pubmed

Protein kinase C regulates the phosphorylation and cellular localization of occludin.

PRKCA PRKCB PRKCG

3.60e-075116311502742
Pubmed

Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.

PRKCA PRKCB PRKCG

3.60e-075116311325528
Pubmed

Protein kinase C activity regulates the onset of anaphase I in mouse oocytes.

PRKCA PRKCB PRKCG

3.60e-075116315229137
Pubmed

Phosphorylation of Munc18 by protein kinase C regulates the kinetics of exocytosis.

PRKCA PRKCB PRKCG

3.60e-075116312519779
Pubmed

Cholecystokinin facilitates glutamate release by increasing the number of readily releasable vesicles and releasing probability.

PRKCA PRKCB PRKCG

3.60e-075116320392936
Pubmed

Extracellular HIV-1 Tat protein induces a rapid and selective activation of protein kinase C (PKC)-alpha, and -epsilon and -zeta isoforms in PC12 cells.

PIK3CG PRKCA PRKCB PRKCG

6.73e-072111649446795
Pubmed

Specific protein kinase C isoforms are required for rod photoreceptor differentiation.

PRKCA PRKCB PRKCG

7.18e-076116322171059
Pubmed

Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current.

PRKCA PRKCB PRKCG

7.18e-076116311306676
Pubmed

Identification of a phosphorylation site for calcium/calmodulindependent protein kinase II in the NR2B subunit of the N-methyl-D-aspartate receptor.

PRKCA PRKCB PRKCG

7.18e-07611638940188
Pubmed

Localization of protein kinase C isoforms in the optic pathway of mouse embryos and their role in axon routing at the optic chiasm.

PRKCA PRKCB PRKCG

7.18e-076116324863469
Pubmed

Expression and activity of protein kinase C isoenzymes during normal and abnormal murine palate development.

PRKCA PRKCB PRKCG

7.18e-076116310879655
Pubmed

The use of fluorescent phorbol esters in studies of protein kinase C-membrane interactions.

PRKCA PRKCB PRKCG

7.18e-076116312093536
Pubmed

An immunohistochemical study of protein kinase C distribution in fetal mouse vertebral column.

PRKCA PRKCB PRKCG

7.18e-07611637985811
Pubmed

PKCε Inhibits Neuronal Dendritic Spine Development through Dual Phosphorylation of Ephexin5.

PRKCA PRKCB PRKCG

7.18e-076116330485813
Pubmed

HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes.

PIK3CG PRKCA PRKCB PRKCG

8.20e-0722116411154208
Pubmed

Sequence determinants on the NR2A and NR2B subunits of NMDA receptor responsible for specificity of phosphorylation by CaMKII.

PRKCA PRKCB PRKCG

1.25e-067116312147342
Pubmed

The myristoylated alanine-rich C-kinase substrate (MARCKS) is sequentially phosphorylated by conventional, novel and atypical isotypes of protein kinase C.

PRKCA PRKCB PRKCG

1.25e-06711637588787
Pubmed

Protein kinase C isoforms differentially phosphorylate human choline acetyltransferase regulating its catalytic activity.

PRKCA PRKCB PRKCG

1.25e-067116315381704
Pubmed

Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4.

PRKCA PRKCB PRKCG

1.25e-067116312958364
Pubmed

14-3-3Gamma interacts with and is phosphorylated by multiple protein kinase C isoforms in PDGF-stimulated human vascular smooth muscle cells.

PRKCA PRKCB PRKCG

1.25e-067116310433554
Pubmed

Conventional protein kinase C-α (PKC-α) and PKC-β negatively regulate RIG-I antiviral signal transduction.

PRKCA PRKCB PRKCG

1.25e-067116322114345
Pubmed

Activation of annexin 7 by protein kinase C in vitro and in vivo.

PRKCA PRKCB PRKCG

1.25e-067116311278415
Pubmed

Signalling crosstalk in FGF2-mediated protection of endothelial cells from HIV-gp120.

PIK3CG PRKCA PRKCB PRKCG

1.41e-0625116415689238
Pubmed

Progesterone induced Warburg effect in HEK293 cells is associated with post-translational modifications and proteasomal degradation of progesterone receptor membrane component 1.

ATR PTPN23 PFKL PFKP PPP6R3

1.51e-0658116531067491
Pubmed

Decreased Anxiety-Related Behaviour but Apparently Unperturbed NUMB Function in Ligand of NUMB Protein-X (LNX) 1/2 Double Knockout Mice.

PFKL NOMO1 NOMO2 SPHKAP PRKCG NOMO3

1.95e-06110116627889896
Pubmed

Developmental expression of MARCKS and protein kinase C in mice in relation to the exencephaly resulting from MARCKS deficiency.

PRKCA PRKCB PRKCG

2.00e-06811638922669
Pubmed

PC phosphorylation increases the ability of AFAP-110 to cross-link actin filaments.

PRKCA PRKCB PRKCG

2.00e-068116312134071
Pubmed

Ki-1/57 interacts with RACK1 and is a substrate for the phosphorylation by phorbol 12-myristate 13-acetate-activated protein kinase C.

PRKCA PRKCB PRKCG

2.00e-068116314699138
Pubmed

Glycogen synthase kinase-3: properties, functions, and regulation.

PRKCA PRKCB PRKCG

2.00e-068116311749387
Pubmed

Distribution of the extended family of protein kinase C isoenzymes in fetal organs of mice: an immunohistochemical study.

PRKCA PRKCB PRKCG

2.00e-06811637606770
Pubmed

Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein.

PRKCA PRKCB PRKCG

2.00e-068116312551925
Pubmed

Nicalin and its binding partner Nomo are novel Nodal signaling antagonists.

NOMO1 NOMO2 NOMO3

2.00e-068116315257293
Pubmed

Protein-protein interaction of zinc finger LIM domains with protein kinase C.

PRKCA PRKCB PRKCG

2.00e-06811638940095
Pubmed

The expression and stage-specific localization of protein kinase C isotypes during mouse preimplantation development.

PRKCA PRKCB PRKCG

2.00e-068116310882525
Pubmed

Protein kinase C phosphorylation of the metabotropic glutamate receptor mGluR5 on Serine 839 regulates Ca2+ oscillations.

PRKCA PRKCB PRKCG

2.00e-068116315894802
Pubmed

Ca2+/calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phosphorylation.

PRKCA PRKCB PRKCG

2.00e-068116310212259
Pubmed

A protein interaction framework for human mRNA degradation.

MAN2C1 MYH13 NOMO1 LSM6 NOMO2 CHPF ABCC10 NOMO3 SLC27A5

2.64e-06347116915231747
Pubmed

Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2.

PRKCA PRKCB PRKCG

2.99e-069116314654844
Pubmed

Regulation of HIV-1 gag protein subcellular targeting by protein kinase C.

PRKCA PRKCB PRKCG

2.99e-06911637876252
Pubmed

Human serum and glucocorticoid-inducible kinase-like kinase (SGKL) phosphorylates glycogen syntheses kinase 3 beta (GSK-3beta) at serine-9 through direct interaction.

PRKCA PRKCB PRKCG

2.99e-069116312054501
Pubmed

Cypher, a striated muscle-restricted PDZ and LIM domain-containing protein, binds to alpha-actinin-2 and protein kinase C.

PRKCA PRKCB PRKCG

2.99e-069116310391924
Pubmed

Phosphorylation of HIV-1 gag proteins by protein kinase C.

PRKCA PRKCB PRKCG

2.99e-06911638473314
Pubmed

Phosphorylation of the cytoplasmic domain of the integrin CD18 chain by protein kinase C isoforms in leukocytes.

PRKCA PRKCB PRKCG

2.99e-069116311700305
Pubmed

aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb.

PRKCA PRKCB PRKCG

2.99e-069116317203073
Pubmed

Inhibition of protein kinase C by a synthetic peptide corresponding to cytoplasmic domain residues 828-848 of the human immunodeficiency virus type 1 envelope glycoprotein.

PRKCA PRKCB PRKCG

2.99e-06911637850771
Pubmed

Human immunodeficiency virus-1 recombinant gp120 induces changes in protein kinase C isozymes--a preliminary report.

PRKCA PRKCB PRKCG

2.99e-06911638206685
Pubmed

Human platelets contain SNARE proteins and a Sec1p homologue that interacts with syntaxin 4 and is phosphorylated after thrombin activation: implications for platelet secretion.

PRKCA PRKCB PRKCG

2.99e-069116310194441
Pubmed

Substrate-driven assembly of a translocon for multipass membrane proteins.

NOMO1 NOMO2 NOMO3

2.99e-069116336261522
Pubmed

The phorbol ester TPA strongly inhibits HIV-1-induced syncytia formation but enhances virus production: possible involvement of protein kinase C pathway.

PRKCA PRKCB PRKCG

4.26e-061011631970444
Pubmed

Btk regulation in human and mouse B cells via protein kinase C phosphorylation of IBtkγ.

PRKCA PRKCB PRKCG

4.26e-0610116321482705
Pubmed

Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.

PRKCA PRKCB PRKCG

4.26e-0610116311884598
Pubmed

Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A.

PRKCA PRKCB PRKCG

4.26e-0610116311035810
Pubmed

Human immunodeficiency virus induces phosphorylation of its cell surface receptor.

PRKCA PRKCB PRKCG

4.26e-061011633259291
Pubmed

Effect of serine and tyrosine phosphorylation on retroviral proteinase substrates.

PRKCA PRKCB PRKCG

4.26e-0610116310491200
Pubmed

Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.

PRKCA PRKCB PRKCG

4.26e-061011632139676
Pubmed

Specific isoforms of protein kinase C are essential for prevention of folate-resistant neural tube defects by inositol.

PRKCA PRKCB PRKCG

5.85e-0611116314613966
Pubmed

IL-16- and other CD4 ligand-induced migration is dependent upon protein kinase C.

PRKCA PRKCB PRKCG

5.85e-061111638599832
Pubmed

Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C.

PRKCA PRKCB PRKCG

5.85e-061111632182321
Pubmed

Phosphorylation of tau is regulated by PKN.

PRKCA PRKCB PRKCG

5.85e-0611116311104762
Pubmed

An ER translocon for multi-pass membrane protein biogenesis.

NOMO1 NOMO2 NOMO3

5.85e-0611116332820719
Pubmed

In vitro phosphorylation of human immunodeficiency virus type 1 Tat protein by protein kinase C: evidence for the phosphorylation of amino acid residue serine-46.

PRKCA PRKCB PRKCG

5.85e-061111638914829
Pubmed

Expression profile of protein kinase C isozymes in preimplantation mouse development.

PRKCA PRKCB PRKCG

5.85e-0611116316183862
Pubmed

HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes: involvement of protein kinase C-betaII and -delta.

PRKCA PRKCB PRKCG

7.78e-0612116311919157
Pubmed

Involvement of protein kinase C in HIV-1 gp120-induced apoptosis in primary endothelium.

PRKCA PRKCB PRKCG

7.78e-0612116311141237
Cytoband2p22-p21

PUM2 NLRC4

1.75e-04811622p22-p21
GeneFamilyC2 domain containing protein kinases

PRKCA PRKCB PRKCG

9.79e-0610803835
GeneFamilyMaestro heat like repeat containing

MROH9 MROH2A MROH5

1.34e-0511803636
GeneFamilyYip1 domain containing

YIPF7 YIPF3

4.00e-047802105
CoexpressionHEVNER_CORTEX_COMMITTED_TO_SUBCEREBRAL_PROJECTION_NEURON_FATE

ADCYAP1 SPHKAP KIT

6.43e-0691133MM429
ToppCellLA-17._Lymphocyte|World / Chamber and Cluster_Paper

SLC24A3 ADCYAP1 JAK3 PIK3CG PRKCB KIT

7.29e-06178116634ec499d03cc198cfefa19a724d4c81974052f65
ToppCellIPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class

SH3TC2 SSTR1 CLDN10 NOMO1 NOMO2 NOMO3

1.12e-051921166e911e286da26202853f9650ba3cdefe5a5c9b585
ToppCellControl-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class

SH3TC2 SSTR1 CLDN10 NOMO1 NOMO2 NOMO3

1.12e-0519211667e89b9125e8b85f6be85eeccef5c8644647ab0e1
ToppCellDiffer-Basal|World / shred by cell class for mouse tongue

NDUFA4L2 PFKL CLDN10 C1QTNF1 KIT CCDC33

1.19e-051941166851eff82c9f3d44c86e3e127a804bbd1fced6a7c
ToppCellControl-Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)

ECPAS AQP3 NOMO1 NOMO2 CHPF

3.90e-051451165fe68582f5a15b9714cb84fa32ac880e13cb69895
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

NACC2 CNTN5 C1QTNF1 VSIG8 KIT

4.30e-0514811655e738522d4ad35e08bc4ff8c41b7bea38ec6ef95
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Ntn1_Npy2r|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

FOXO1 SLC24A3 CNTN5 C1QTNF1 KIT

4.89e-0515211658ff5a178a8f3550d89a003c0858820aab3773386
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

MYH13 SLC24A3 ANO5 SSTR1 NACC2

6.23e-0516011650bfdaf979e6f128cba2928ce16bca4d3deff8ac9
ToppCelldroplet-Fat-Scat-21m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MYH13 DTX1 NLRC4 PRKCB KLHL14

6.42e-051611165e52735f955f0a53da5cbe5a2d77a00484e5109b3
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXO1 DTX1 ADCYAP1 PRKCG KLHL14

6.61e-05162116522f1abd20f43bc7e7fc46969da9962faf70ae5d2
ToppCellfacs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FOXO1 DTX1 ADCYAP1 PRKCG KLHL14

6.61e-051621165966df4558140c3d541999ab553f201ae76a1c401
ToppCelldroplet-Heart-4Chambers-18m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCR10 CAPN3 NAA25 EXOC3L1

7.57e-05861164d20ec61a572b11641647358a546334b217c694f3
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

ATR PIGV TECPR2 TLR4 PARP12

7.63e-051671165a54b8e03987a7b067173121902e1811a3d003692
ToppCellfacs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

MRGPRF YIPF7 AQP3 SPHKAP VSIG8

7.63e-05167116578909f685ccd1321064eb0887caf9263e0e54879
ToppCellmild_COVID-19_(asymptomatic)-Plasmablast|World / disease group, cell group and cell class (v2)

CCR10 TEDC2 AQP3 KLHL14 CHPF

7.63e-051671165f26ae4de4804a3486502e3df37eabf3dfca688f5
ToppCellControl-Mast_cells|Control / group, cell type (main and fine annotations)

SLC24A3 ADCYAP1 PRKCA PRKCB KIT

8.07e-051691165fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

SLC24A3 ADCYAP1 PRKCB SLC25A47 KIT

8.07e-0516911652e15a9317da4017757d184f7cc91bd66b072ac51
ToppCellCOVID-19-lung-MAST|lung / Disease (COVID-19 only), tissue and cell type

SLC24A3 ADCYAP1 PRKCA PRKCB KIT

8.30e-051701165e90f18e5462381b38e918442b38b1c8105291908
ToppCellControl-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations)

SLC24A3 ADCYAP1 PRKCA PRKCB KIT

8.30e-051701165c80f6d29096c372da95a8407f402349ff1bb7018
ToppCelldroplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM150A NDUFA4L2 NACC2 C1QTNF1 CHPF

9.26e-051741165cdfc50e5383c8670ce5109736aff36406f46c03d
ToppCellCOVID-19-lung-MAST|COVID-19 / Disease (COVID-19 only), tissue and cell type

SLC24A3 ADCYAP1 PRKCA PRKCB KIT

9.77e-051761165473c45a381ca109207d66ed1635668b391ea0e1f
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

TEDC2 NLRC4 SBNO2 TLR4 PRKCB

1.00e-04177116568f1139fc378f351e3b9e9f392aacb150025bf03
ToppCellfacs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

MRGPRF CLDN10 SEC22C PIGA SLC19A1

1.03e-041781165cb9a446c145b1435cfe12a1d4568aed0924a6a20
ToppCelldroplet-Spleen-SPLEEN-1m-Lymphocytic-plasma_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CCR10 TMEM150A NDUFA4L2 CHPF ABCC10

1.03e-041781165b902059c3f861108fc64cbdc05e6f44378f5be2c
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51B ZNF628 RIPK1 NLRC4 SLC19A1

1.06e-0417911652c3abd646d2c8992e8ff76a824eab5beba8ba4c6
ToppCelldroplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RAD51B ZNF628 RIPK1 NLRC4 SLC19A1

1.06e-0417911656eb84fe9691ad40127b2d1f1c672428333c8fab4
ToppCelldroplet-Marrow-nan-21m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM150A NDUFA4L2 NACC2 C1QTNF1 CHPF

1.11e-04181116597022416d0f5a5ba9c9bd5e70ce95cf4cb19af89
ToppCellLA-17._Lymphocyte|LA / Chamber and Cluster_Paper

SLC24A3 ADCYAP1 JAK3 PRKCB KIT

1.11e-0418111653fd9f805fa46141b0fa7023ee5d8688d338635d5
ToppCellIIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster

PSKH1 TRUB2 PNPO SLC2A11 PARP12

1.14e-0418211655c7d02da9ca2bca49db9832704b6894dfaa08a71
ToppCelldroplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM150A NDUFA4L2 NACC2 C1QTNF1 CHPF

1.23e-041851165238938a4682b44e88a30b86b13af4feeabe9553d
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.30e-041871165d2296f2722a24b289fed7e6cfdc2105608437c3e
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.30e-04187116506a0f0a27569af89f86ed8cddb608454a3d40cc5
ToppCellPBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-04189116573ee4cfb1057832f700be59b6917dedde3e89880
ToppCellPBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-041891165a1bda6ed5c52a5d33d229018cb5982cae6305533
ToppCellPBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-04189116531594cc59eb1c5b01407dfd72b1487ecca8bf5ec
ToppCellCOVID-19_Mild-Lymphoid_P|COVID-19_Mild / Disease group, lineage and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-0418911650b3d3bd697e79decae7e21c513fab9da3b2a47c5
ToppCellPBMC-Mild-Lymphocyte-B-Plasmablast-Plasmablast-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-041891165c296660061b46e3abae1e7cf29df20274e5a8add
ToppCellCOVID-19_Mild-Lymphoid_P-Plasmablast|COVID-19_Mild / Disease group, lineage and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-041891165254f058850b41a5974a380f3710db7c01a51fb6b
ToppCellPBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-041891165f2daf4889ef98bbefe3e44832618ac102a75b4d9
ToppCelltumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass

CCR10 NDUFA4L2 PRKCB C1QTNF1 EGFLAM

1.36e-041891165f4865b7db16de15120504147a8016ac522ad242a
ToppCellPBMC-Mild-Lymphocyte-B-Plasmablast|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.36e-0418911659de17ade3cc3e9cd1394338bd048fb1ce64ac50f
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.40e-04190116584eb7761f537d270673909a71d4f122e826769d5
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.40e-041901165f85cdd79eefd699ada7a91bf4997cc730a9b9846
ToppCellfacs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANO5 YIPF7 ASB14 RHD CNTN5

1.43e-041911165543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f
ToppCellCOPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class

SH3TC2 CLDN10 NOMO1 NOMO2 NOMO3

1.43e-041911165ef16ad1c1cd2c0c0377957398c98775b62a81754
ToppCellfacs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ANO5 YIPF7 ASB14 RHD CNTN5

1.43e-0419111659d7d680da3979e256191b534ebd14c5383e0cf93
ToppCellCOVID-19_Moderate-Plasmablast|World / disease group, cell group and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.43e-041911165bb28703020c5296b65527094d2e5924348275e58
ToppCellControl-Plasmablast|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)

CCR10 AQP3 NOMO1 NOMO2 CHPF

1.43e-0419111653df5bbdb29bbcbcb8476fdf126b6d4c1ac67d64b
ToppCellPrimary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

RAD51B FOXO1 SH3TC2 CAPN3 TLR4

1.43e-0419111652b056cbe2e82e056e1f798974999378460eb1d16
ToppCellfacs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EPB41L3 SPHKAP PRKCA PRKCB CHPF

1.47e-0419211655b7093d5af5ae7b0e6d3a464cc56272440ecedad
ToppCellCOVID-19_Moderate-Plasmablast|COVID-19_Moderate / disease group, cell group and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.47e-04192116525c6c7a244190f82c7feab874bdec12490b7de4d
ToppCellCOVID-19_Severe-Lymphoid_P|COVID-19_Severe / Disease group, lineage and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.47e-0419211653d0240491296757b3125f6e861bbaca06bbc5068
ToppCellCOVID-19_Severe-Lymphoid_P-Plasmablast|COVID-19_Severe / Disease group, lineage and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.47e-04192116590af8dad4e6f80b5ecd62027deeb2e4cea6b24bb
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.50e-041931165227d82059a9f99937e0188ff57f2d0e485ebfe69
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.50e-04193116538bb14df7f05c29565a1c7f175fafe636e543bf8
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.50e-0419311653ba6d44248690b80f4caf791d463e60f1ab816c4
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.50e-041931165ce3873ece35fd2155ea235cb3c8bcd235cc0ebde
ToppCellPBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.50e-0419311658f57b0473a2c2c07f83e5fe70f16862b1bb3b514
ToppCellsevere-Plasmablast|World / disease stage, cell group and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.54e-04194116549e8f90db571a89b8a26aef31fcacd66429fed11
ToppCellIPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class

FOXO1 SH3TC2 TCN2 NDUFA4L2 C1QTNF1

1.54e-041941165e8a9005963704286bcc50785bda8d7d63ec001b1
ToppCellControl_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type

ASB14 DNAH1 LRRC9 SLC17A8 CCDC33

1.58e-04195116560067b5359174f0d1a8b5748bfc0690762e9e740
ToppCellCOVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class

TCN2 EPB41L3 NLRC4 TLR4 ADGRE1

1.62e-041961165256c557fa11414c9d2cbb1fcff33f482ee1c78ac
ToppCellPBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters

PHF12 NOMO1 JAK3 PIK3CG KIT

1.62e-04196116509d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCellNeuron-Postmitotic-Excitatory_Neuron_-Deep_Layer-37|World / Primary Cells by Cluster

SLC24A3 SPHKAP PRKCB PRKCG KIT

1.66e-04197116500d756bc0231e1b3b88430214338c1059cb11106
ToppCellCOVID_vent-Lymphocytic-Plasma_cell-IgA_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass

AQP3 NOMO1 NOMO2 CHPF NOMO3

1.66e-04197116599fe44ef42c65d24fe64947fd5bf6d91b9a4b2c3
ToppCellParenchymal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

GRK7 CLDN10 JAK3 PIK3CG PRKCB

1.69e-041981165c64238379798ae6b292cc1914d60548c88e652de
ToppCellTCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9

PFKL CDC42BPB TECPR2 C1QTNF1

1.70e-04106116414f548be39cec604fbdae0382cbf434fa4049840
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9

PFKL CDC42BPB TECPR2 C1QTNF1

1.70e-041061164939b80950d39cdc7149a05fdfb64c8810064cdb1
ToppCellTCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9

PFKL CDC42BPB TECPR2 C1QTNF1

1.70e-041061164e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48
ToppCellCOVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.73e-041991165e6422b65e22e5aa8dfaebdae5be76dd78b978604
ToppCellTracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_activated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

MYH13 NLRC4 PNPO JAK3 LOXL3

1.73e-0419911656dc446a5d183b01bdf227e45bd88d0b3d8b1c56a
ToppCellCOVID-19-COVID-19_Mild-Lymphocyte-B-Plasmablast|COVID-19_Mild / Disease, condition lineage and cell class

CCR10 AQP3 NOMO1 KLHL14 CHPF

1.73e-04199116546f31aef26c3da7608082f750d743ad54adbc51a
ToppCellParenchymal-NucSeq-Immune_Myeloid-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC24A3 ADCYAP1 PRKCA PRKCB KIT

1.78e-0420011659156f8fd61a833891d2f7b7fadd693b81b1e2d5a
ToppCellParenchymal-NucSeq-Immune_Myeloid-Mast_cell-Mast_cell|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SLC24A3 ADCYAP1 PRKCA PRKCB KIT

1.78e-042001165566fe2e78e6f35399ec6aad5964f6d4d8ade82c6
ToppCellsevere-CD163+_Monocytes_(Sample_ID1_d7)|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TCN2 EPB41L3 NLRC4 NACC2 TLR4

1.78e-0420011654943fe826d5fcc3dfeb8b99a7415848f3fecc994
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Intermediate|GW23 / Sample Type, Dataset, Time_group, and Cell type.

TRPM4 SSTR1 NOMO1 NACC2 CNTN5

1.78e-042001165fe772d98c461c973dfc082e1fc50117c27ced804
Drug1-stearoyl-2-arachidonoyl-sn-glycerol

TRPM4 PRKCA PRKCB PRKCG DAGLA

1.80e-06401165CID000001398
DiseaseAdenocarcinoma of large intestine

RIPK1 CDC42BPB PRKCA PRKCB KIT

3.49e-05961135C1319315
DiseaseChronic myeloproliferative disorder

ATR JAK3 KIT

5.07e-05191133C1292778
Diseaseglycogen storage disease (implicated_via_orthology)

PFKL PFKP

8.68e-0541132DOID:2747 (implicated_via_orthology)
Diseasetotal glycated albumin

CNTN5 PRKCA

1.44e-0451132EFO_0009305
Diseasemean reticulocyte volume

RAD51B FOXO1 ATR PSKH1 RHD SBNO2 OPRL1 SLC19A1 CNTN5 ABCC10 SLC27A5

2.54e-0479911311EFO_0010701
DiseaseParkinson's disease (implicated_via_orthology)

FOXO1 SSTR1 PTCH1 OPRL1 SLC17A8

3.54e-041571135DOID:14330 (implicated_via_orthology)
DiseaseCleft upper lip

TCN2 PTCH1 SLC19A1

4.52e-04391133C0008924
Diseasegamma-glutamylthreonine measurement

OR5K3 ADGRE1

6.41e-04101132EFO_0021143
DiseaseLeukoencephalopathy

TCN2 SCP2

7.82e-04111132C0270612
Diseasecystatin C measurement

GTPBP4 TFAP2D CLDN10 DNAH1 NAA25 C1QTNF1 KIT

9.27e-044021137EFO_0004617
Diseasealcohol use disorder (implicated_via_orthology)

GRK7 OPRL1 PRKCA PRKCB PRKCG

9.44e-041951135DOID:1574 (implicated_via_orthology)
DiseasePneumoconiosis

ATR MDM4

1.28e-03141132C0032273
DiseaseBagassosis

ATR MDM4

1.28e-03141132C0004681
DiseaseChildhood Ataxia with Central Nervous System Hypomyelinization

TCN2 SCP2

1.28e-03141132C1858991
DiseaseAutosomal recessive limb-girdle muscular dystrophy

CAPN3 ANO5

1.28e-03141132cv:C2931907
Diseaseobesity (implicated_via_orthology)

CAPN3 PUM2 TLR4 SCP2 PUM1

1.45e-032151135DOID:9970 (implicated_via_orthology)
DiseaseMalignant neoplasm of skin

PTCH1 AQP3 KIT

1.52e-03591133C0007114
DiseaseSkin Neoplasms

PTCH1 AQP3 KIT

1.52e-03591133C0037286
DiseaseHETE measurement

RAD51B FAM91A1 SEC22C

1.75e-03621133EFO_0801166
Diseaseovarian neoplasm

ATR WNT7A AQP3 TLR4

1.79e-031341134C0919267
DiseaseMalignant neoplasm of ovary

ATR WNT7A AQP3 TLR4

1.94e-031371134C1140680
DiseaseGrand Mal Status Epilepticus

CCR10 SSTR1 PNPO

2.19e-03671133C0311335
DiseaseStatus Epilepticus, Subclinical

CCR10 SSTR1 PNPO

2.19e-03671133C0751522
DiseaseSimple Partial Status Epilepticus

CCR10 SSTR1 PNPO

2.19e-03671133C0751524
DiseaseNon-Convulsive Status Epilepticus

CCR10 SSTR1 PNPO

2.19e-03671133C0751523
DiseasePetit mal status

CCR10 SSTR1 PNPO

2.19e-03671133C0270823
DiseaseComplex Partial Status Epilepticus

CCR10 SSTR1 PNPO

2.19e-03671133C0393734
DiseaseStatus Epilepticus

CCR10 SSTR1 PNPO

2.29e-03681133C0038220
Diseaseetiocholanolone glucuronide measurement

NLRC4 ZNF799

2.38e-03191132EFO_0800362
Diseaseestrogen-receptor negative breast cancer

RAD51B FAM91A1 MDM4

2.59e-03711133EFO_1000650
Diseaseserum alanine aminotransferase measurement, response to combination chemotherapy

MYH13 CSMD2 PIGV

2.59e-03711133EFO_0004735, EFO_0007965
Diseaseexercise test

CNTN5 PRKCA

2.64e-03201132EFO_0004328
DiseaseSevere Combined Immunodeficiency

TCN2 JAK3

2.64e-03201132C0085110
DiseaseInfiltrating duct carcinoma of female breast

ATR CDC42BPB

2.91e-03211132C3165106
Diseasedisease of metabolism (implicated_via_orthology)

PFKL PFKP

2.91e-03211132DOID:0014667 (implicated_via_orthology)

Protein segments in the cluster

PeptideGeneStartEntry
IAYLCGHLHTLGGLM

TMEM62

251

Q0P6H9
QYLSALMQGRLVCRG

EXOC3L1

596

Q86VI1
AAVVNAIGLYMRHLG

ARHGEF1

216

Q92888
GVMVACYALLGRTLL

CCR10

221

P46092
TNRQYMRGLVGCISH

EGFLAM

976

Q63HQ2
GLACFIYGLLSMEHN

ANO5

321

Q75V66
NAGYRLVGHSMAICT

CSMD2

2496

Q7Z408
YIGCNHMALEIFLRG

CCDC33

376

Q8N5R6
VLYVMDLSEQCGHGL

GTPBP4

251

Q9BZE4
ILRMYIALTGLQHAG

ACAD9

431

Q9H845
MGNYELISLLLRHGA

ASB14

396

A6NK59
ALDGYIQACRGLMIA

CLDN10

71

P78369
HDGSNSYRLMQLGCL

TFAP2D

16

Q7Z6R9
LLMHAGRYGCRVQTT

CNTN5

641

O94779
VTGLSYRGVHELLCM

RAD51B

41

O15315
RQTGYMLRCSLSHAI

NOMO3

586

P69849
YRHLVLLHGVCMAGD

JAK3

581

P52333
CILYNLGALHSMLGA

PTPN23

116

Q9H3S7
GHVLPLALQMYGCRV

PUM2

801

Q8TB72
GICMRLIVLSYLGGN

OR5I1

141

Q13606
MHSLEVLHLGYNGIC

LRRC9

1201

Q6ZRR7
ANHLLHRCILGMLSY

ABCC10

761

Q5T3U5
MSQRLCHVLVGIQYL

OR8K5

136

Q8NH50
RQTGYMLRCSLSHAI

NOMO2

586

Q5JPE7
ICHPLRYNVLMSLRG

OR10H5

126

Q8NGA6
MVACRQLGLGYANHG

LOXL3

456

P58215
MKHLAAVYQHGCLLG

NLRC4

506

Q9NPP4
QHMVYCGGDLLGELL

MDM4

71

O15151
YLGNHMNIVNLLGAC

KIT

646

P10721
RVDLQHLCGYVTMLN

FAM91A1

646

Q658Y4
MVLDGVRYLHALGIT

PSKH1

201

P11801
VLYLRMCLAHSAGVV

ECPAS

596

Q5VYK3
EVMGRHCGYLALVSA

PFKL

206

P17858
VMGRHCGYLALVSAL

PFKP

216

Q01813
SALLRLYCALMGIAG

INTS2

386

Q9H0H0
RQTGYMLRCSLSHAI

NOMO1

586

Q15155
DHCGSLLYGLIHQGM

PRKCB

116

P05771
HCGSLLYGLVHQGMK

PRKCG

116

P05129
CIQMTAGAYLAGNLH

OR5K3

141

A6NET4
YLSHLCGRSAAMDLG

PNPO

21

Q9NVS9
HCTSLMVGLIRQGYA

CDC42BPB

1041

Q9Y5S2
VCDALRYSAIMHGGL

OR2F1

126

Q13607
RYSAIMHGGLCARLA

OR2F1

131

Q13607
RYSAIMHGGLCARLA

OR2F2

131

O95006
SLGMCHLLYIARCQN

MROH9

191

Q5TGP6
ELVGRLGRCGHMYHL

DTX1

436

Q86Y01
LGRCGHMYHLLCLVA

DTX1

441

Q86Y01
RQGAVVLHVLCAIYM

SLC24A3

106

Q9HC58
IRGHVLSLALQMYGC

PUM1

921

Q14671
VGLCAQLHLCRFMVY

PARP12

86

Q9H0J9
LICLGMGSAALYLLR

NDUFA4L2

26

Q9NRX3
CIRLVAGSYIMGSIN

OR5AK2

141

Q8NH90
GARLALLVYGIIMHS

ADCYAP1

6

P18509
QCILANLIYMGHVKG

PCID2

361

Q5JVF3
ITVPMCRGIGYNLTH

FZD5

36

Q13467
AYTGRVRSNIHMVLC

DNAH1

2701

Q9P2D7
LGQLVCTLHGMFYLT

ATR

711

Q13535
VSSCNGYGRMGLLHQ

FOXO1

581

Q12778
GRRVLLIGGYSLMTC

SLC2A11

336

Q9BYW1
HTLAVMNDRLYAIGG

KLHL14

511

Q9P2G3
MGSRGQGLLLAYCLL

C1QTNF1

1

Q9BXJ1
YSAQLPQIMHGCGIR

MAN2C1

376

Q9NTJ4
RGVLACLDGYMNIAL

LSM6

31

P62312
VDHGRGYLGILLSCM

DAGLA

56

Q9Y4D2
ACGMLHLHELGIVYR

GRK7

301

Q8WTQ7
QYETRMACGLVRGHA

CAPN3

321

P20807
LLFICLGNMYLHGLR

SEC22C

256

Q9BRL7
IMLGVCASGLLIYRD

EPB41L3

311

Q9Y2J2
CQFLMALSIVRTGGH

CMTR1

386

Q8N1G2
LIGNMCSIHLLIFYR

NPHP1

571

O15259
ICNPLRYSVLMGHGV

OR10K1

126

Q8NGX5
ICNPLRYSVLMGHGV

OR10K2

126

Q6IF99
LLGNCLVMYVILRHT

OPRL1

66

P41146
RCSLEGASHLYQLLM

MROH5

651

Q6ZUA9
MAILHIIGQLALCGY

MROH2A

446

A6NES4
CQLSGMHLLVGRYLE

HSPBP1

141

Q9NZL4
LGIQLVIYLACAAGM

TAAR5

31

O14804
LLINGIAGYLHLLAM

UTP18

356

Q9Y5J1
VGLCGNSMVIYVILR

SSTR1

71

P30872
CLYRRGGTDHITNML

SPHKAP

1291

Q2M3C7
GAFMVALICLLRYGQ

TMEM150A

86

Q86TG1
YRCLLTLEGLQAMVG

TEDC2

296

Q7L2K0
DHCGSLLYGLIHQGM

PRKCA

116

P17252
GAACRHMDIFLGILL

MRGPRF

191

Q96AM1
LLGLGGAVNMCYRTL

PHF12

801

Q96QT6
LVLNGGCHGLSRKYM

PTCH1

321

Q13635
GQRRYRGLLHCMVTS

SLC25A47

251

Q6Q0C1
LQGLRLRHHYMLCGA

SBNO2

1156

Q9Y2G9
LTHGLLCYEMALLFG

SH3TC2

936

Q8TF17
GRIILEIIEGMCYLH

RIPK1

116

Q13546
CGQRAIYHSLGMTGI

SCP2

71

P22307
QYGLGILALCLHQKR

TCN2

156

P20062
RNIKMLHICAFGYGL

ADGRE1

706

Q14246
AGVFVYQLMIGCHLE

AQP3

256

Q92482
RYCHGGFGVLLSRML

CHPF

241

Q8IZ52
MGGVESHIYQLSQCL

PIGA

46

P37287
ILEAYLRGCGTAMLH

PIK3CG

716

P48736
AAVLLLFGGLCMHVQ

PIGV

386

Q9NUD9
SAYLLHVGNLCLVMG

TSPAN16

51

Q9UKR8
CSMLIEEGGLQHLYN

ZYG11B

686

Q9C0D3
MRVGGAFHLLLVCLS

VSIG8

1

P0DPA2
CNRVLGIPHSSIMGY

RHD

316

Q02161
LYHVMGLVVGILGCL

SLC27A5

336

Q9Y2P5
YFLGAMLDGLRHCQR

SLC19A1

446

P41440
VIMGHSSLNCYIRVG

ZNF799

111

Q96GE5
YLVMHQLRCNGVLEG

MYH13

691

Q9UKX3
GSSIGMLYLYCRHLN

TECPR2

51

O15040
LQMLALLGYGLFGHC

YIPF3

216

Q9GZM5
RRCLGHLFLSLGMVY

WNT7A

6

O00755
VLGVGHGCRLLTDMY

TRUB2

106

O95900
YGMSAIGCLVIHALL

YIPF7

176

Q8N8F6
FHLMLLAGCIKYGRG

TLR4

656

O00206
GYMGHLTRIANCIVH

PPP6R3

456

Q5H9R7
GLYHLGRTVLCIDFM

TRPM4

886

Q8TD43
HYGCVMCVRILQGLV

SLC17A8

181

Q8NDX2
ICGRGFVMAAYLQRH

ZNF628

626

Q5EBL2
GSGVYITRGQLMNCH

NACC2

351

Q96BF6
CVVQLTRLLGLYHTM

NAA25

416

Q14CX7